Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario (Sep, 10.1007/s00432-020-03377-6, 2020)

被引：0
|
作者：
Lerner-Ellis, Jordan [1 ,2 ,3 ]
Mighton, Chloe [2 ,4 ,5 ]
Lazaro, Conxi [2 ,6 ,7 ]
Watkins, Nicholas [2 ,8 ]
Di Gioacchino, Vanessa [2 ]
Wong, Andrew [2 ]
Chang, Martin C. [1 ,9 ]
Charames, George S. [1 ,2 ,3 ]
机构：
[1] Univ Toronto, Dept Lab Med & Pathobiol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada
[2] Mt Sinai Hosp, Dept Pathol & Lab Med, Sinai Hlth, Toronto, ON, Canada
[3] Sinai Hlth, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[4] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[5] St Michaels Hosp, Genom Hlth Serv Res Program, Li Ka Shing Knowledge Inst, Toronto, ON, Canada
[6] ICO IDIBELL, Hereditary Canc Program, Barcelona, Spain
[7] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada
[8] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada
[9] Univ Vermont, Canc Ctr, Burlington, VT USA
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 2021年 / 147卷 / 08期
关键词：
D O I：
10.1007/s00432-020-03399-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In the original article published, the proportions for the categories "Non-AJ, non-FC, non-Hispanic White" and "Other ethnicity" have incorrectly been reversed. The correct values for "Non-AJ, non-FC, non-Hispanic White" should be 62.3% (2024) and "Other ethnicity" should be 4.2% (136).
引用
收藏
页码：2487 / 2487
页数：1
相关论文
共 20 条
  • [1] Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario
    Jordan Lerner-Ellis
    Chloe Mighton
    Conxi Lazaro
    Nicholas Watkins
    Vanessa Di Gioacchino
    Andrew Wong
    Martin C. Chang
    George S. Charames
    [J]. Journal of Cancer Research and Clinical Oncology, 2021, 147 : 871 - 879
  • [2] Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario
    Lerner-Ellis, Jordan
    Mighton, Chloe
    Lazaro, Conxi
    Watkins, Nicholas
    Di Gioacchino, Vanessa
    Wong, Andrew
    Chang, Martin C.
    Charames, George S.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (03) : 871 - 879
  • [3] Correction to: Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario
    Jordan Lerner-Ellis
    Chloe Mighton
    Conxi Lazaro
    Nicholas Watkins
    Vanessa Di Gioacchino
    Andrew Wong
    Martin C. Chang
    George S. Charames
    [J]. Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2487 - 2487
  • [4] Economic impact of multigene panel testing for hereditary breast and ovarian cancer
    Byfield, Stacey Dacosta
    Wei, Helen
    DuCharme, Mary
    Lancaster, Johnathan M.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (03) : 207 - 217
  • [5] Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
    Desmond, Andrea
    Kurian, AllisonW.
    Gabree, Michele
    Mills, Meredith A.
    Anderson, Michael J.
    Kobayashi, Yuya
    Horick, Nora
    Yang, Shan
    Shannon, Kristen M.
    Tung, Nadine
    Ford, JamesM.
    Lincoln, Stephen E.
    Ellisen, Leifw.
    [J]. JAMA ONCOLOGY, 2015, 1 (07) : 943 - 951
  • [6] Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
    Howarth, D. T. R.
    Lum, Sharon S.
    Esquivel, Pamela
    Garberoglio, Carlos A.
    Senthil, Maheswari
    Solomon, Naveenraj L.
    [J]. AMERICAN SURGEON, 2015, 81 (10) : 941 - 944
  • [7] Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer
    Ryu, Jin-Sun
    Lee, Hye-Young
    Cho, Eun Hae
    Yoon, Kyong-Ah
    Kim, Min-Kyeong
    Joo, Jungnam
    Lee, Eun-Sook
    Kang, Han-Sung
    Lee, Seeyoun
    Lee, Dong Ock
    Lim, Myong Cheol
    Kong, Sun-Young
    [J]. CANCER SCIENCE, 2020, 111 (10) : 3912 - 3925
  • [8] Evaluation of criteria for genetic study of hereditary breast and ovarian cancer BRCAX families by multigene panel testing
    Castillo-Guardiola, V.
    Sarabia-Meseguer, M. D.
    Macias-Cerrolaza, J. A.
    Garcia-Aliaga, A.
    Rosado-Jimenez, L.
    Sanchez-Bermudez, A. I.
    Zafra-Poves, M.
    Moreno-Locubiche, M. A.
    Pascual-Gilabert, P.
    Aliaga-Bano, A.
    Noguera-Velasco, J. A.
    Ayala De La Pena, F.
    Ruiz-Espejo, F.
    [J]. CLINICA CHIMICA ACTA, 2019, 493 : S576 - S577
  • [9] Multigene panel testing for hereditary breast and ovarian cancer syndrome: experience from a tertiary referral hospital
    Potrony, Miriam
    Morales-Romero, Blai
    Moreno, Lorena
    Pastor, Belen
    Villanueva-Canas, Jose L.
    Badenas, Celia
    Aragon Manrique, Isabel
    Carrasco Salas, Pilar
    Aguilera, Paula
    Ferrer-Mileo, Laura
    Gaba, Lydia
    Adamo, Barbara
    Oriola, Josep
    Sanchez, Aurora
    Puig-Butille, Joan A.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 400 - 400
  • [10] The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
    Eliade, Marie
    Skrzypski, Jeremy
    Baurand, Amandine
    Jacquot, Caroline
    Bertolone, Geoffrey
    Loustalot, Catherine
    Coutant, Charles
    Guy, France
    Fumoleau, Pierre
    Duffourd, Yannis
    Arnould, Laurent
    Delignette, Alexandra
    Padeano, Marie-Martine
    Lepage, Come
    Raichon-Patru, Geraldine
    Boudrant, Axelle
    Bone-Lepinoy, Marie-Christine
    Villing, Anne-Laure
    Charpin, Aurelie
    Peignaux, Karine
    Chevrier, Sandy
    Vegran, Frederique
    Ghiringhelli, Francois
    Boidot, Romain
    Sevenet, Nicolas
    Lizard, Sarab
    Faivre, Laurence
    [J]. ONCOTARGET, 2017, 8 (02) : 1957 - 1971
12